NOW-fertility is pleased to announce Dr Antoine Abu Musa joining the corporation as Chief Medical Officer.
Dr Abu Musa is a well-respected expert in infertility and IVF with 30 years of clinical experience, and a former President of the Lebanese Society of Obstetrics and Gynaecology.
He received his MD and specialty training from the American University of Beirut followed by subspecialty training in Japan, and he was awarded a PhD in 1993. He joined the Department of Obstetrics and Gynecology at the American University of Beirut Medical Center in June 1993 as Assistant Professor and became a full Professor in 2010. He was appointed vice-chair of the department in 2014. In addition, he was Head of the REI (Reproductive Endocrinology & Infertility) Division and Director of the REI fellowship program until 2021 when he joined Faruk Medical City in Kurdistan, Iraq as Head of the REI Division.
Within NOW-fertility, Dr Abu Musa will lead the Company’s team on medical and scientific affairs. He will be responsible globally for the implementation of clinical protocols and standard operating procedures, ensuring safety and compliance with good and sound clinical and scientific practice. He will help to grow and scale the operations of NOW-fertility internationally, being instrumental in introducing new clinical services within the various Regions, leading the clinical team in collaboration with the Regional Medical Directors.
Dr Abu Musa commented “NOW-fertility is the future of infertility management. I am proud and honoured to be part of this future.”
Whilst Professor Luciano Nardo, CEO and Founder of NOW-fertility, commented “I am delighted to welcome Dr Abu Musa to be part of the senior management group. He will liaise with the clinical and scientific teams within our partner clinics to deliver outstanding and attentive clinical care to patients, as well as contributing to research activities, audits and publications.”
NOW-fertility is a new digital platform set to deliver innovative care globally using a next-generation platform to offer a considerably faster and more personalised fertility journey for patients and a more efficient model for IVF clinics.
